Eicosanoids regulation of transcription factors in PC-3 prostate cancer cells

Advances in Experimental Medicine and Biology

Volumn 507, Issue , 2002, Pages 563-568

  Kandouz, Mustapha ^a   Honn, Kenneth V ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 12 LIPOXYGENASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1;

BINDING AFFINITY; CANCER CELL CULTURE; CARCINOGENESIS; CARCINOMA CELL; CONFERENCE PAPER; CONTROLLED STUDY; DNA BINDING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WILD TYPE; ARTICLE; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PROSTATE TUMOR;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ARACHIDONATE 12-LIPOXYGENASE; EICOSANOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0037769626     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0193-0_86     Document Type: Conference Paper

References (18)

1. Devary, Y. et al., 1993, NF-kappa B activation by ultraviolet light not dependent on a nuclear signal, Science 261:1442-1445.
2. Baeuerle, P.A., and Baltimore, D., 1996, NF-kappa B: ten years after, Cell 87:13-20.
3. Baeuerle, P.A., and Henkel, T., 1994, Function and activation of NF-kappa B in the immune system, Annu. Rev. Immunol. 12:141-179.
4. Barnes, P.J., and Karin, M., 1997, Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases, N. Engl. J. Med. 336:1066-1071.
5. Meyer, M., Schreck, R., Baeuerle, P.A., 1993, H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor, EMBO J. 12:2005-2015.
6. Beg, A.A., and Baltimore, D., 1996, An essential role for NF-kappaB in preventing TNF-alpha-induced cell death, Science 274:782-784.
7. Foo, S.Y., and Nolan, G.P., 1999, NF-kappaB to the rescue: RELs, apoptosis and cellular transformation, Trends Genet., 15:229-235.
8. Whiteside, S.T., and Israel, A., 1997, I kappa B proteins: structure, function and regulation, Semin. Cancer Biol. 8:75-82.
9. DiDonato, J.A., et al., 1997, A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB, Nature 388:548-554.
10. Zandi, E., and Karin, M., 1999, Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex, Mol Cell Biol. 19:4547-51.
11. Shaywitz, A.J., and Greenberg, M.E., 1999, CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals, Annu. Rev. Biochem. 68:821-861.
12. Tada, M., Kobayashi, H., and Moriuchi, T., 1999, Molecular basis of pituitary oncogenesis, J. Neurooncol. 45:83-96.
13. Bertherat, J., Chanson, P., and Montminy, M., 1995, The cyclic adenosine 3′,5′-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas, Mol. Endocrinol. 9:777-783.
14. Gao, X., et al., 1995, Elevated 12-lipoxygenase messenger-RNA expression correlates with advanced-stage and poor differentiation of human prostate-cancer, Urology 46:227-237.
15. Nie, D., et al., 1998, Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. Cancer Res. 58:4047-4051.
16. Traenckner, E.B., et al., 1995, Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli, EMBO J. 14:2876-2883.
17. Rayet, B., and Gelinas, C., 1999, Aberrant rel/nfkb genes and activity in human cancer, Oncogene 18:6938-6947.
18. Sovak, M.A., et al., 1997, Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer, J Clin Invest. 100:2952-2960.